Advancing the Science

Mayo Clinic Medical Science Blog

Items Tagged ‘Mayo Clinic Cancer Center’

February 28th, 2017

More women eligible for Herceptin, benefit uncertain

By Nicole Brudos Ferrara nicoleferrara

Updated guidelines underscore need to identify the most optimal candidates for HER2-directed therapy. Changes to HER2 testing guidelines for breast cancer in 2013 significantly increased the number of patients who test positive for HER2 breast cancer, Mayo Clinic researchers have found. The researchers published their HER2 breast cancer study results online July 25, 2016, in […]

View full entry · Comment on this

Tags: Breast Cancer, cancer research, Dr Robert Jenkins, Forefront, HER2, Journal of Clinical Oncology, Mayo Clinic Cancer Center


February 16th, 2017

Drug combo safe for diffuse large B-cell lymphoma

By Nicole Brudos Ferrara nicoleferrara

  Drugs targeting the P13K-mTOR pathway add benefit when combined with standard R-CHOP therapy.   The drug everolimus can be safely combined with R-CHOP for new, untreated diffuse large B-cell lymphoma, according to the results of a pilot study by Mayo Clinic researchers. The researchers published their study findings in the July 2016 issue of […]

View full entry · Comment on this

Tags: diffuse large B-cell lymphoma, Dr Patrick Johnston, everolimus, Forefront, lymphoma, Mayo Clinic Cancer Center, non-Hodgkin lymphoma, R-CHOP


February 5th, 2017

Researchers identify unique breast microbiome

By Nicole Brudos Ferrara nicoleferrara

A team of Mayo Clinic researchers has identified evidence of bacteria in breast tissue and found differences between women with and without breast cancer. These research findings were published in the August 3, 2016, issue of Scientific Reports. “Our research found that breast tissue samples obtained in the operating room under sterile conditions contain bacterial […]

View full entry · Comment on this

Tags: Breast Cancer, Dr Amy Degnim, Dr Nick Chia, Dr Tina Hieken, Forefront, Mayo Clinic Cancer Center, microbiome


January 19th, 2017

Stereotactic radiosurgery is best for some brain tumors

By Elizabeth Zimmermann Young elizabethzimmermann

Shift in practice may reserve whole-brain radiation for patients with extensive disease. Patients with three or fewer metastatic brain tumors who received treatment with stereotactic radiosurgery (SRS) had less cognitive deterioration three months after treatment than did patients who received SRS combined with whole-brain radiation therapy. This finding is among the results of a federally […]

View full entry · Comment on this

Tags: brain tumor, Cancer, Mayo Clinic Cancer Center, Paul D Brown, stereotactic radiosurgery


January 17th, 2017

Avoid routine double mastectomy when possible

By Elizabeth Zimmermann Young elizabethzimmermann

Consensus group urges weighing pros, cons and patient preference in unilateral breast cancer. A position paper issued by the American Society of Breast Surgeons recommends against contralateral prophylactic mastectomy (CPM) for average-risk women with breast cancer in only one breast. The recommendation on prophylactic mastectomy, published online July 28, 2016, in the Annals of Surgical […]

View full entry · Comment on this

Tags: American Society of Breast Surgeons, Breast Cancer, double mastectomy, Forefront, Judy Boughey, Mayo Clinic Cancer Center


January 10th, 2017

Meet the Investigator: Jamie N. Bakkum-Gamez, M.D.

By Elizabeth Zimmermann Young elizabethzimmermann

At the Mayo Clinic Cancer Center, hundreds of researchers dedicate their professional lives to reducing the burden of cancer. Each one has a unique story. In this issue, Jamie N. Bakkum-Gamez, M.D., a gynecologic oncologist at Mayo Clinic in Rochester, Minnesota, discusses her research. This is one of a series of Meet the Investigator interviews […]

View full entry · Comment on this

Tags: Alan Bryce, cancer research, Forefront, Jamie Bakkum-Gamez, Joseph Mikhael, Mayo Clinic Cancer Center, Meet the Investigator, Minetta Liu, richard joseph


December 13th, 2016

Nipple-sparing mastectomy may be a good option

By Elizabeth Zimmermann Young elizabethzimmermann

Technique offers a safe way to reduce breast cancer risk in carriers of the BRCA mutation. Mastectomies that preserve the nipple and surrounding skin prevent breast cancer as effectively as do more-invasive surgeries for women with a genetic mutation called BRCA, a multi-institution study led by Mayo Clinic Cancer CenterĀ found. The study findings were presented […]

View full entry · Comment on this

Tags: BRCA, Breast Cancer, Forefront, James Jakub, mastectomy, Mayo Clinic Cancer Center, nipple-sparing


December 1st, 2016

State-of-the-art nanomedicine research launched

By Elizabeth Zimmermann Young elizabethzimmermann

With support from the state of Florida, Mayo Clinic’s campus in Jacksonville, Florida, has opened a state-of-the-art laboratory for nanotechnology research, an emerging field of science that studies and applies materials that are the size of an atom. The laboratory is a key part of Mayo Clinic’s new Translational Nanomedicine Program. The goal is to […]

View full entry · Comment on this

Tags: Cancer, Debabrata Mukhopadhyay, Dev Mukhopadhyay, Florida, Gianrico Farrugia, Mayo Clinic Cancer Center, nanomedicine, nanotechnology


November 17th, 2016

Aspirin use may help prevent bile duct cancer

By Elizabeth Zimmermann Young elizabethzimmermann

Bile duct cancer is an uncommon cancer that forms in the slender tubes (bile ducts) that carry digestive fluid through the liver. Bile duct cancer occurs mostly in people older than age 50. Symptoms include yellowing of the skin and eyes, intense itchiness of the skin, and white stools. Bile duct cancer is an aggressive […]

View full entry · Comment on this

Tags: Bile duct cancer, Cancer, Lewis Roberts, Mayo Clinic Cancer Center


October 27th, 2016

“The Pill” associated with better ovarian cancer outcomes

By Elizabeth Zimmermann Young elizabethzimmermann

If a woman takes oral contraceptives, it provides not only reduced risk of developing ovarian cancer, but also better outcomes if she does get this deadly cancer. “Multiple studies from a variety of sources have indicated that oral contraceptives are associated with a reduced risk of ovarian cancer, one of the most deadly cancers in […]

View full entry · Comment on this

Tags: Aminah Jatoi, ovarian cancer, Mayo Clinic Cancer Center


Contact Us · Privacy Policy